MedTrace Logo

A Singapore Study to Assess How Neurovision Improve the Vision of Adults With Low to Moderate Myopia

NCT00348075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-05-12

No results posted yet for this study

Summary

To evaluate the efficacy of NeuroVision NVC vision correction technology to improve the vision of subjects with Low and Moderate Myopia in Asian eyes in Singapore

Conditions

  • Myopia

Interventions

DEVICE

Neurovision

Sponsors & Collaborators

  • Defence Medical Research Institute, Singapore Armed Forces

    collaborator UNKNOWN

  • NeuroVision

    collaborator INDUSTRY

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Donald Tan, FRCS · Singapore Eye Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348075 on ClinicalTrials.gov